News
Research commissioned by Innovate UK and the British In Vitro Diagnostics Association (BIVDA) has revealed that the NHS could save over £6.9...
Shares in Sarepta Therapeutics rocketed by 80% after the company released preliminary data from a Phase 1/2a trial showing that its experimental...
Kallyope and Novo Nordisk have entered into a research collaboration and option agreement to discover novel peptide therapeutics for the treatment...
A blood test designed to support the clinical determination of whether a child is on the autistic spectrum has been proven to be highly successful...
Despite its highly-publicised transgressions recently, tech giant Facebook is looking to do the right thing by wading into the ongoing US opioid...
Boston-based Ziopharm Oncology, has fallen foul of the FDA as the US regulator slapped a clinical hold on its Phase 1 trial into its CD19-specific...
PTC Therapeutics was able to post data from a Phase 1 trial showing 90% of babies given the treatment showed signs of improvement.
Beleaguered pharma firm Valeant has come up against another bump in the road as its plaque psoriasis lotion Duobrii was rejected for US approval by...
Roche has clearly seen significant potential in Foundation Medicine’s work in genomics to pay $2.4 billion to take complete ownership of the company.
Going from the youngest female self-made billionaire in the world to being charged with engaging in schemes to defraud investors is a pretty...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches
